Devyser Diagnostics AB (FRA:OL0) Accounts Payable: €1.68 Mil (As of Mar. 2026)


FRA:OL0 Devyser Diagnostics AB FRA:OL0
73 GF Score
Price €5.51
GF Value €13.86
! 2 Warning Signs
View Full Analysis

What is Devyser Diagnostics AB Accounts Payable?

Devyser Diagnostics AB FRA:OL0 +0.92% 73 Accounts Payable is €1.68 Mil as of Mar. 2026. GuruFocus rates FRA:OL0 with a GF Score™ of 73/100 and a GF Value™ of €13.86. The stock has 2 warning signs investors should review.

Devyser Diagnostics AB's Accounts Payable for the quarter that ended in Mar. 2026 was €1.68 Mil.

Devyser Diagnostics AB's quarterly Accounts Payable increased from Sep. 2025 (€0.96 Mil) to Dec. 2025 (€1.65 Mil) and increased from Dec. 2025 (€1.65 Mil) to Mar. 2026 (€1.68 Mil).

Devyser Diagnostics AB's annual Accounts Payable declined from Dec. 2023 (€1.27 Mil) to Dec. 2024 (€1.10 Mil) but then increased from Dec. 2024 (€1.10 Mil) to Dec. 2025 (€1.65 Mil).

Devyser Diagnostics AB Accounts Payable Related Terms

Devyser Diagnostics AB Accounts Payable Historical Data

* Premium members only.

The historical data trend for Devyser Diagnostics AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Devyser Diagnostics AB Accounts Payable Chart

Devyser Diagnostics AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only 0.94 0.87 1.27 1.10 1.65

Devyser Diagnostics AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.99 0.65 0.96 1.65 1.68
FRA:OL0
73GF Score
Devyser Diagnostics AB FRA:OL0
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Devyser Diagnostics AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €1.68 Mil mean?
Devyser Diagnostics AB (FRA:OL0) has a Accounts Payable of €1.68 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Devyser Diagnostics AB and its competitors.
Is Devyser Diagnostics AB's Accounts Payable too high?
Devyser Diagnostics AB's current Accounts Payable is €1.68 Mil. Overall, Devyser Diagnostics AB has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Devyser Diagnostics AB's Accounts Payable compare to ABT and SYK?
Devyser Diagnostics AB's Accounts Payable of €1.68 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Devyser Diagnostics AB and its competitors. Devyser Diagnostics AB's current Accounts Payable is €1.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Devyser Diagnostics AB stock overvalued right now?
Devyser Diagnostics AB (FRA:OL0) has a current Accounts Payable of €1.68 Mil. The stock's GF Value™ is €13.86, compared to a current price of €5.51 — trading 60.2% below its estimated fair value. The current Accounts Payable is €1.68 Mil. Devyser Diagnostics AB's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Devyser Diagnostics AB (FRA:OL0), the current Accounts Payable is €1.68 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Devyser Diagnostics AB (FRA:OL0) Overvalued in 2026?

Based on GuruFocus' analysis, Devyser Diagnostics AB stock appears to be undervalued. The current stock price of €5.51 is trading 60.2% below its estimated GF Value™ of €13.86.

Key valuation signals for FRA:OL0:

  • Accounts Payable: €1.68 Mil
  • GF Value™: €13.86 vs. price of €5.51 (60.2% below fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the FRA:OL0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Devyser Diagnostics AB Business Description

Other Exchanges DVYSR:Sweden
Address Branningevagen 12, Arsta, SWE, 120 54
Devyser Diagnostics AB is engaged in the development, manufacture, and sale of kits for genetic testing in routine diagnostic laboratories. The products are used for advanced genetic testing in the hereditary disease, oncology, and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.
73GF Score

Get the complete analysis for FRA:OL0

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.51
Price
€13.86
GF Value